Carbapenemase-Producing Non-Glucose-Fermenting Gram-Negative Bacilli in Africa, Pseudomonas aeruginosa and Acinetobacter baumannii : A Systematic Review and Meta-Analysis

International Journal of Microbiology
Mizan KinduFeleke Moges

Abstract

Studies have reported that the existence of CP bacteria in Africa, but, in general, comprehensive data about the molecular epidemiology of CP organisms are limited. Therefore, this systematic review and meta-analysis expound the pooled prevalence of CP P. aeruginosa and CP A. baumannii clinical isolates in Africa. It also identified the diversity of carbapenemases or their encoding genes among the isolates in Africa. Lastly, the review observed the trends of these CP isolates in Africa. A comprehensive search was performed between July 2019 and October 2019 in the following databases: PubMed, Google Scholar, and African Journal online. The included articles were published only in English. The screening was done by two authors independently. The data extracted on Excel spreadsheet were transferred to STATA 11 software for analysis. From a total of 1,454 articles searched, 42 articles were eligible. Most of the studies were conducted in the North Africa region. But there was no report from Central Africa. The pooled prevalence of CP P. aeruginosa and CP A. baumannii among the clinical specimens in Africa was 21.36% and 56.97%, respectively. OXA-23 and VIM were the most prevailing carbapenemase among P. aeruginosa and A. baumannii...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Sep 29, 2001·Journal of Clinical Epidemiology·J A Sterne, M Egger
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Feb 1, 1993·International Journal of Antimicrobial Agents·R PatonS G Amyes
Nov 21, 2008·Journal of Evaluation in Clinical Practice·John P A Ioannidis
Oct 18, 2011·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Sep 12, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Atef ShiblAbdullah Assiri
Dec 11, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Imane SefraouiJean-Marc Rolain
Mar 13, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Mohamed H Al-AgamyAmany El Kholy
Apr 4, 2014·Clinical Microbiology Reviews·Benjamin A Evans, Sebastian G B Amyes
May 3, 2014·BioMed Research International·Laurent DortetPatrice Nordmann
Sep 23, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Sofiane BakourJean-Marc Rolain
Sep 28, 2014·The Journal of Antimicrobial Chemotherapy·Rendani I ManenzheMamadou Kaba
Jan 15, 2015·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Najla MathlouthiJean-Marc Rolain
Mar 25, 2015·Antimicrobial Agents and Chemotherapy·Mohamed Abd El-Gawad El-Sayed-AhmedJean-Marc Rolain
Apr 17, 2015·BMC Infectious Diseases·Mai Mahmoud ZaferSeif El Din Ashour
Jun 16, 2015·Antimicrobial Resistance and Infection Control·Samah MeradjiMohammed Timinouni
Sep 8, 2015·Contemporary Clinical Trials·Rebecca DerSimonian, Nan Laird
Dec 30, 2015·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Itto MarouiAbdelhaq Belhaj
Jan 23, 2016·Critical Care Research and Practice·Hamid VaezHajieh Ghasemian Safaei
May 10, 2016·Burns : Journal of the International Society for Burn Injuries·Samah MeradjiMohammed Timinouni
May 25, 2016·International Journal of Antimicrobial Agents·Najla MathlouthiChedly Chouchani
Jun 18, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Fatma Zohra MelloukJean Marc Rolain
Sep 7, 2016·Virulence·David van Duin, Yohei Doi
Nov 5, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ahmad Al AtrouniMarie Kempf
Feb 14, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hazim O KhalifaTadashi Shimamoto
Mar 3, 2017·BMC Infectious Diseases·Michael PritschAndreas Wieser
Mar 16, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Hany HashemAlaa Saad
May 11, 2017·Annals of Clinical Microbiology and Antimicrobials·Doaa Mohammad GhaithOmar Almoazzamy
Jul 12, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Najla MathlouthiChedly Chouchani
Dec 22, 2017·Medical Sciences : Open Access Journal·Francis S Codjoe, Eric S Donkor
Dec 26, 2017·The Lancet Infectious Diseases·Evelina TacconelliUNKNOWN WHO Pathogens Priority List Working Group
Jan 11, 2018·Polish Journal of Microbiology·Amani F AbazaGehan S A Aly
Feb 13, 2018·Journal of Global Antimicrobial Resistance·Siew Mun LiewKek Heng Chua
Mar 20, 2018·Revista Argentina de microbiología·Carlos Hernán RodríguezAngela Famiglietti

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.